Cargando…

SARS-CoV2 infection as a potential trigger for severe relapse in a patient with multiple sclerosis who stopped disease modifying treatment due to COVID-19 pandemic

BACKGROUND: During COVID-19 pandemic safety of disease modifying treatments (DMT) in patients with multiple sclerosis (MS) is still under debate. While there is no clear evidence for a higher risk of severe SARS-CoV-2 infection under DMT the risk of rebound of disease activity in case of stopping DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Auer, Michael, Berek, Klaus, Fava, Elena, Zinganell, Anne, Deisenhammer, Florian, Hegen, Harald, Di Pauli, Franziska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285927/
http://dx.doi.org/10.1016/j.nerep.2021.100005